QI
DCPH

QS Investors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

QS Investors’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19,700
Closed -$1.18M – 1590
2020
Q2 		$1.18M Hold
19,700
– – 0.02% 676
2020
Q1 		$812K Hold
19,700
– – 0.01% 721
2019
Q4 		$1.14M Sell
19,700
-200
-1% -$9.51K 0.01% 748
2019
Q3 		$676K Hold
19,900
– – 0.01% 871
2019
Q2 		$449K Sell
19,900
-500
-2% -$11.7K ﹤0.01% 1001
2019
Q1 		$474K Buy
+20,400
New +$534K 0.01% 993

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

QS Investors's DCPH Position: Q3 2020 in Review

QS Investors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2020, closing a stake of 19,700 shares — an estimated $1.18M sold.

QS Investors first reported a position in DCPH in Q1 2019 and held it in 6 quarters. The position peaked at $1.18M in Q2 2020. 161 funds tracked by Wall St. Rank hold DCPH as of Q3 2020.

  • QS Investors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • QS Investors sold 19,700 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $1.18M.
  • QS Investors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 6 quarters.
  • QS Investors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.18M in Q2 2020.
  • 161 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.